Jane Street Group LLC Has $22.18 Million Stock Holdings in Haleon PLC Sponsored ADR $HLN

Key Points

• Jane Street Group LLC significantly increased its stake in Haleon PLC by933.1%, acquiring an additional 1,947,050 shares, bringing its total ownership to over 2.15 million shares valued at approximately$22.18 million.
• Several other institutional investors also raised their stakes in Haleon, with notable increases including a697.2% boost from Millennium Management LLC and a22% increase from Wellington Management Group LLP.
• Haleon announced a semi-annual dividend of $0.0555, reflecting a positive change from its previous dividend, with an ex-dividend date set for August 15th.

Jane Street Group LLC boosted its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 933.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,155,716 shares of the company's stock after purchasing an additional 1,947,050 shares during the quarter. Jane Street Group LLC's holdings in Haleon were worth $22,182,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Bartlett & CO. Wealth Management LLC boosted its position in Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after purchasing an additional 1,491 shares in the last quarter. Banque Transatlantique SA purchased a new stake in Haleon during the first quarter worth $27,000. Opal Wealth Advisors LLC purchased a new stake in Haleon during the first quarter worth $29,000. Deutsche Bank AG boosted its position in Haleon by 267.8% during the first quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock worth $32,000 after purchasing an additional 2,276 shares in the last quarter. Finally, Continuum Advisory LLC boosted its position in Haleon by 152.4% during the first quarter. Continuum Advisory LLC now owns 4,753 shares of the company's stock worth $49,000 after purchasing an additional 2,870 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Stock Performance

Shares of Haleon stock traded down $0.14 on Thursday, reaching $9.26. 11,513,446 shares of the company were exchanged, compared to its average volume of 8,268,631. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. The company's 50-day moving average is $9.67 and its two-hundred day moving average is $10.18. The firm has a market cap of $41.45 billion, a price-to-earnings ratio of 23.74, a P/E/G ratio of 2.77 and a beta of 0.24. Haleon PLC Sponsored ADR has a 1-year low of $8.86 and a 1-year high of $11.42.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be given a $0.0555 dividend. The ex-dividend date is Friday, August 15th. This represents a yield of 190.0%. This is an increase from Haleon's previous semi-annual dividend of $0.05. Haleon's payout ratio is 28.21%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HLN shares. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a report on Tuesday, May 27th. Barclays lowered Haleon from an "overweight" rating to an "equal weight" rating in a research note on Tuesday. The Goldman Sachs Group upgraded Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday, September 10th. Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Finally, BNP Paribas upgraded Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Haleon has a consensus rating of "Moderate Buy" and an average price target of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.